Zobrazeno 1 - 6
of 6
pro vyhledávání: '"John K. Connolly"'
Autor:
Lorenzo Toselli, Per Pfeffer, Raymond Dandavino, Steven J. Chadban, Matthias Büchler, L. Pallardó, Maria Scolari, Francesco Paolo Schena, Edward S. Cole, César Agost Carreno, Eric Thervet, Helen Pilmore, John K. Connolly
Publikováno v:
Transplantation. 76:903-908
Background. MO2ART (monitoring of 2-hr absorption in renal transplantation) is the first prospective, multicenter trial of cyclosporine (CsA) blood level 2 hr postdose (C 2 ) monitoring in de novo kidney recipients receiving CsA microemulsion (ME) (N
Autor:
Robert W. G. Johnson, N. Parrott, Philip A. Dyer, Susan Martin, John K. Connolly, Robert Pearson
Publikováno v:
Transplantation. 61:709-714
Univariate and multivariate analyses have been performed on donor an d recipient variables to determine possible effects on the outcome of 516 primary cadaveric renal transplants performed in our single center from 1989 until 1993. The overall actuar
Autor:
Aisling E. Courtney, John K. Connolly, J. Ashley Jefferson, C C Doherty, Brian Herron, Mark O. McCarron
Publikováno v:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 4(7)
Myositis is a rare complication following renal transplantation and is most commonly the result of drug-mediated myotoxicity. Other causative disorders include viral infection, electrolyte imbalance and myositis of autoimmune origin. We describe a 60
Autor:
Arun D, Pherwani, Paul C, Winter, Peter T, McNamee, Chris C, Patterson, Claire M, Hill, John K, Connolly, A Peter, Maxwell
Publikováno v:
Transplantation. 76(3)
This single center study is the largest series of renal transplant recipients and donors screened for the commonest prothrombotic genotypes. A total of 562 transplant recipients and 457 kidney donors were genotyped for the factor V Leiden and prothro
Publikováno v:
Transplant immunology. 1(4)
Between January 1989 and June 1991 329 consecutive cadaveric renal transplants were carried out at this centre and, of those, 36 (10.9%) have failed. In order to assess whether the use of flow cytometry crossmatching (FCXM) would have predicted these
Autor:
John K. Connolly, David Deardon, Velokaren J. Jos, Robert Pearson, N. Parrott, Robert W. G. Johnson
Publikováno v:
Transplantation. 58:389